Company intelligence / Profile preview

Uniques

Ownership: Private
Development stage: Other

Overview

Uniques is a biotechnology company focused on the development of innovative therapeutic solutions for rare diseases and oncology. The company leverages its proprietary research to identify and optimize small molecule candidates targeting unmet medical needs. Uniques aims to advance its pipeline through strategic collaborations and internal development programs. The company is currently in the pre-clinical stage, with several programs undergoing lead optimization and IND-enabling studies.

Therapeutic areas: OncologyRare Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Uniques.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Uniques.

Explore the full profile